Tiande Chemical Holdings Limited

HKEX:0609.HK

1.13 (HKD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023202220212020201920182017201620152014201320122011201020092008200720062005
Revenue 2,080.2853,520.6082,584.7311,359.3931,381.1381,179.31,407.3291,265.3891,123.4081,121.1271,195.1781,003.895972.163881.775598.947725.199574.298504.187430.817
Cost of Revenue 1,641.4412,042.1731,806.8611,178.2591,195.7511,114.1461,124.684869.088806.519836.955852.29742.292752.402658.007501.675626.076505.315405.62358.594
Gross Profit 438.8441,478.435777.87181.134185.38765.154282.645396.301316.889284.172342.888261.603219.761223.76897.27299.12368.98398.56772.223
Gross Profit Ratio 0.2110.420.3010.1330.1340.0550.2010.3130.2820.2530.2870.2610.2260.2540.1620.1370.120.1950.168
Reseach & Development Expenses 67.87885.23582.40246.87838.0957.5965.7193.3264.9516.73612.25100000000
General & Administrative Expenses 112.693128.827134.34394.57687.90670.4375.04849.81444.69845.44448.08633.80835.1430.12626.27831.39827.41123.43610.152
Selling & Marketing Expenses 58.45577.78285.07651.4950.8352.57344.75743.69435.40835.23327.36122.21221.61123.08922.63427.82719.09912.96312.712
SG&A 171.148209.989223.323150.202140.882123.003119.80593.50880.10680.67775.44756.0256.75153.21548.91259.22546.5136.39922.864
Other Expenses 1.6773.5811.3959.5342.6015.3085.4575.2574.6154.2773.8464.996-5.25310.055-4.7990.61103.7443.344
Operating Expenses 160.805193.431235.90759.631151.69136.132127.76174.27772.58172.35578.44755.57651.49863.2744.11359.83646.5140.14326.208
Operating Income 267.6961,268.446554.54730.93244.505-57.849162.84302.793236.783203.495267.441212.496168.263160.49853.15939.28722.47358.42446.015
Operating Income Ratio 0.1290.360.2150.0230.032-0.0490.1160.2390.2110.1820.2240.2120.1730.1820.0890.0540.0390.1160.107
Total Other Income Expenses Net 30.40816.505-18.29180.187-13.988-16.081-7.89321.88510.2549.153-8.312-15.67-6.642-7.237-10.304-12.720.6673.9691.91
Income Before Tax 298.1041,284.951536.256111.11930.517-73.93154.947324.678247.037212.648259.129196.826161.621153.26142.85526.56723.1462.39347.925
Income Before Tax Ratio 0.1430.3650.2070.0820.022-0.0630.110.2570.220.190.2170.1960.1660.1740.0720.0370.040.1240.111
Income Tax Expense 66.627326.964143.80633.13818.875.21454.433105.21974.66658.14371.04337.64429.26124.0350.8111.6421.5864.3756.214
Net Income 211.071870.924379.64794.82121.507-61.058101.562219.603172.371154.505188.086159.182132.36129.22642.04424.92521.55458.01841.711
Net Income Ratio 0.1010.2470.1470.070.016-0.0520.0720.1740.1530.1380.1570.1590.1360.1470.070.0340.0380.1150.097
EPS 0.241.010.450.110.025-0.0720.120.260.20.180.220.190.160.160.0530.0310.0270.0920.07
EPS Diluted 0.2410.450.110.025-0.0720.120.260.20.180.220.190.160.160.0530.0310.0270.0920.07
EBITDA 436.3891,395.722678.074144.804154.53643.899253.083383.212306.142267.934321.939257.992210.083199.61190.53673.80222.47358.59246.183
EBITDA Ratio 0.210.3960.2620.1070.1120.0370.180.3030.2730.2390.2690.2570.2160.2260.1510.1020.0390.1160.107